LOGO
LOGO

FDA Calendar - Vera Therapeutics, Inc.

Company Name Vera Therapeutics, Inc.
VERA
Drug Name Atacicept (BLA)
Event Name FDA decision on atacicept for the treatment of adults with immunoglobulin A nephropathy (IgAN)
Event Date 07/07/2026
Outcome Date
Outcome pending
Drug Status Priority Review
Rival Drugs If approved, atacicept would be the first B cell modulator targeting both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) for immunoglobulin A nephropathy (IgAN).
Market Potential
Other Approvals
News
Return to FDA Calendar
RELATED NEWS (Vera Therapeutics, Inc.)
Editors Pick
dollartree 28052026 lt

Dollar Tree Stock Up 13% On Q1 Results, Positive Outlook, Deal With DoorDash

May 28, 2026 08:13 ET
dicksportinggoods 27052026 lt

DICK'S Sporting Cuts FY26 Earnings View, Backs Adj. EPS, Sales Forecast After Q1 Growth; Stock Down

May 27, 2026 09:46 ET
airfranceairbus 22052026 lt

French Court Rules Air France And Airbus Guilty In 2009 Plane Crash; Companies To Appeal

May 22, 2026 05:33 ET
walmart 21052026 lt

Walmart Sees Growth In Q2, Backs FY27 Outlook After Strong Q1; Stock Down

May 21, 2026 08:33 ET
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap